Novo Nordisk CEO on safety concerns associated with off-label use of diabetes drugs
Share

Novo Nordisk CEO on safety concerns associated with off-label use of diabetes drugs

CNBC's Meg Tirrell joins 'Closing Bell' to report on rapid prescription growth for diabetes medicine, celebrities using Ozempic and Wegovy for weight loss and the safety related to broad use of medicines.
02:08
Mon, Feb 6 20234:03 PM EST